Abstract:We read with interest the article by Torisu et al. on the protective role of suppressor of cytokine signaling-1 (SOCS1), a negative-feedback molecule for cytokine signaling, in concanavalin A (ConA)-induced hepatitis.1 The authors observed that hepatocyte-specific SOCS1-conditional knockout (L-SOCS1 cKO) mice showed enhanced ConA-induced hepatitis compared with wild-type mice. They also found that proapoptotic signals, including signal transducers and activators of transcription 1 (STAT1), Jun-terminal kinase (JNK) activation, and Fas expression were also elevated in L-SOCS1 cKO mice. The authors attribute the mechanism to the prevention of Fas and tumor necrosis factor-α–induced hepatocyte apoptosis. SOCS1 is a known inhibitor of cytokine signaling pathways and has been shown to be a regulator of immune tolerance. T cells from SOCS1−/− mice can proliferate after anti–T cell receptor stimulation in the absence of interleukin-2 (IL-2) or anti-CD28 costimulatory signals.2 In addition, SOCS1 expression is very high in CD4+CD25+ regulatory T cells (Tregs), which has led to the possibility that SOCS1 is involved in Treg function.3 Indeed, the suppressive activity of SOCS1-deficient Tregs is less than that of wild-type Tregs.4 Recently, Tregs were found to mediate the tolerance in ConA-induced hepatitis.5 This suppressive effect was caused by the induction of IL-10 produced by Tregs and the accompanying inhibition of IL-2. However, the mechanisms by which Tregs induce tolerance and alleviate liver injury in ConA-induced hepatitis still remain to be elucidated. In addition, it is well known that Con A-induced liver injury is mainly caused by the accumulation of activated T cells and natural killer T cells, which is the result of dysfunction of Tregs. So, further research should be carried out to investigate SOCS1 functions of Tregs in ConA-induced hepatitis. These studies will not only improve our knowledge about the molecular mechanism of Treg function in hepatitis, but also bring great benefits to the treatment and prevention of liver diseases. Yichuan Xiao*, Yanyun Zhang* , * Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences/Shanghai Jiao Tong University School of Medicine, Shanghai, China, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Taraxasterol mitigates Con A-induced hepatitis in mice by suppressing interleukin-2 expression and its signaling in T lymphocytes

Stephanthraniline A Suppressed CD4(+) T Cell-Mediated Immunological Hepatitis Through Impairing PKCθ Function.

TPN10466 ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting ERK/JNK/p38 signaling pathway

Celastrol pretreatment attenuates concanavalin A-induced hepatitis in mice by suppressing interleukin-6/STAT3-interleukin-17 signaling

Stephanthraniline A And Cyclosporine A Synergize To Inhibit T-Cell Response In Vitro And In Vivo

Sodium Tanshinone IIA Sulfonate Protects Mice From ConA-Induced Hepatitis via Inhibiting NF-κB and IFN-γ/STAT1 Pathways

The Protective Effects of Levo-Tetrahydropalmatine on ConA-Induced Liver Injury Are Via TRAF6/JNK Signaling

Total flavonoids from Tetrastigma hemsleyanum ameliorates inflammatory stress in concanavalin A-induced autoimmune hepatitis mice by regulating Treg/Th17 immune homeostasis

Astaxanthin Alleviates Autoimmune Hepatitis by Modulating CD8+ T Cells: Insights From Mass Cytometry and Single‐Cell RNA Sequencing Analyses

Diammonium Glycyrrhizinate Mitigates Liver Injury Via Inhibiting Proliferation of NKT Cells and Promoting Proliferation of Tregs

Antimalarial agent artesunate protects Concanavalin A-induced autoimmune hepatitis in mice by inhibiting inflammatory responses

Protective Effects of Astaxanthin on ConA-induced Autoimmune Hepatitis by the JNK/p-JNK Pathway-Mediated Inhibition of Autophagy and Apoptosis.

Inhibition of NLRP3 Inflammasome Activation and Pyroptosis in Macrophages by Taraxasterol Is Associated With Its Regulation on mTOR Signaling

TPN10475 Alleviates Concanavalin A-induced Autoimmune Hepatitis by Limiting T Cell Development and Function Through Inhibition of PI3K-AKT Pathway

Sodium Tanshinone Iia Sulfonate Protects Mice From Cona-Induced Hepatitis Via Inhibiting Nf-Kappa B And Ifn-Gamma/Stat1 Pathways

Tectorigenin Protects Against Experimental Fulminant Hepatic Failure by Regulating the TLR4/mitogen‐activated Protein Kinase and TLR4/nuclear Factor‐κb Pathways and Autophagy

Tripterygium wilfordii protects against an animal model of autoimmune hepatitis

Protective role of synthetic oligodeoxynucleotides expressing immunosuppressive TTAGGG motifs in concanavalin A-induced hepatitis

Suppressor of Cytokine Signaling-1, a Possible Cause for Regulatory T Cells in Hepatitis?

The JAK inhibitor tofacitinib ameliorates immune‑mediated liver injury in mice

Total astragalus saponins attenuate primary sclerosing cholangitis in mice by upregulation of TGR5